coveringkey aspects of the industry’s evolution and identifying potential future growthopportunities.
Roots Analysis has done a detailedstudy on DrugRepurposing Service Providers Market, 2020-2030.”
coveringkey aspects of the industry’s evolution and identifying potential future growthopportunities.
To order this 250+ page report, which features 100+ figuresand 140+ tables, please visit this https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
Key Market Insights
§ More than 60 industry players across the world are presentlyengaged in providing services for the repurposing of therapeutics
§ The dataset features a variety of CRO, big data / analyticsand technology-based service providers, offering repurposing services by usingdifferent type of repurposing approaches and drug molecules
§ Over 1,700 discontinued clinical studies of therapeutics canbe considered as potential candidates for repurposing
§ In the pursuit of obtaining an edge within this emergingand highly competitive market landscape, service providers are actively exploringthe therapeutic potential of the existing approved drugs by providing thenecessary support to drug developers in identifying / predicting prospectivedrug candidates for repurposing.
§ Over time, recent initiatives havebeen undertaken by big pharma players across the world for the discovery anddevelopment of repurposed drugs
§ Several organizations have extended financial support toaid research efforts in this domain; the current focus is on investigation ofnovel immune checkpoint pathways / targets for coronavirus disease
§ The growing interest in this fieldis also reflected by the 10+ partnerships have been signed in the last threeyears, involving both international and indigenous stakeholders
§ The future market, based on the revenue generationpotential of repurposed drugs, is anticipated to be distributed across differentdisease areas and key geographical regions
§ In the long term, the opportunity is likely to be segmentedacross type of repurposing approaches, purpose of repurposing and type of drugmolecule
Formore information, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview ofDrug Repurposing
3.2.1 History ofDrug Repurposing
3.2.2 Strategiesfor Drug Repurposing
3.3. Repurposingversus the Traditional Drug Discovery
3.4. Benefitsand Challenges Associated with Drug Repurposing
3.5. DrugRepurposing Service Providers
4. MARKETLANDSCAPE
4.1. ChapterOverview
4.2. DrugRepurposing Service Provider: Overall Market Landscape of Contract ResearchOrganizations (CROs)
4.2.1. Analysis byYear of Establishment
4.2.2. Analysis byCompany Size
4.2.3. Analysis byLocation of Headquarters
4.2.4. Analysis byCompany Size and Location of Headquarters
4.2.5. Analysis byType of Drug Molecule
4.2.6. Analysis byStatus of Drug
4.2.7. Analysis byRepurposing Approach
4.2.8. Analysis byServices Offered
4.3. DrugRepurposing Service Provider: Overall Market Landscape of Big Data / AnalyticsService Providers
4.3.1. Analysis byYear of Establishment
4.3.2. Analysis byCompany Size
4.3.3. Analysis byLocation of Headquarters
4.3.4. Analysis byCompany Size and Location of Headquarters
4.3.5. Analysis byTechnology Specifications
4.3.6. Analysis byType of Drug Molecule
4.3.7. Analysis byStatus of Drug
4.3.8. Analysis byRepurposing Approach
4.3.9. Analysis byServices Offered
4.4. Drug RepurposingService Provider: Overall Market Landscape of Technology Providers
4.4.1. Analysis byYear of Establishment
4.4.2. Analysis byCompany Size
4.4.3. Analysis byLocation of Headquarters
4.4.4. Analysis byCompany Size and Location of Headquarters
4.4.5. Analysis byTechnology Specifications
4.4.6. Analysis byType of Drug Molecule
4.4.7. Analysis byStatus of Drug
4.4.8. Analysis byRepurposing Approach
4.2.9. Analysis byServices Offered
5. ROLE OF NON-PROFIT / ACADEMIC ORGANIZATIONS
5.1. ChapterOverview
5.2. DrugRepurposing Service Providers: List of Non-Profit Organizations
5.3. StakeholderProfiles
5.3.1. Cures WithinReach
5.3.2. GlobalCures
5.3.3. AnticancerFund
5.3.4. NationalCenter for Advancing Translational Sciences
5.4. DrugRepurposing Service Providers: List of Academic Organizations
6. COMPANY PROFILES
6.1. ChapterOverview
6.2. CompanyProfiles for CROs
6.2.1. AuxiliisPharma
6.2.1.1. Company Overview
6.2.1.2. Service Portfolio
6.2.1.3. Future Outlook
6.2.2. ChemBioDiscovery Solutions
6. 2.2.1. Company Overview
6. 2.2.2. Service Portfolio
6. 2.2.3. Future Outlook
6.2.3. GVK BIO
6.2.3.1. Company Overview
6.2.3.2. Technology Overview
6.2.3.3. Service Portfolio
6.2.3.4. Future Outlook
6.2.4. Iris Pharma
6.2.4.1. Company Overview
6.2.4.2. Service Portfolio
6.2.4.3. Future Outlook
6.2.5. Physiogenex
6.2.5.1. Company Overview
6.2.5.2. ServicePortfolio
6.2.5.3. Future Outlook
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
